Inventor
ANDO HARUHI
JP21 patents
⚠️ This page may combine multiple inventors who share the name “ANDO HARUHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
15 patentsUS9586930B2Mar 7, 2017
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO3 citations83
US9440990B2Sep 13, 2016
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO7 citations83
US11560372B2Jan 24, 2023
Heterocyclic compounds useful as modulators of acetylcholine receptors
TAKEDA PHARMACEUTICALS CO2 citations73
US11174272B2Nov 16, 2021
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations73
US10550129B2Feb 4, 2020
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations73
US10273245B2Apr 30, 2019
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations73
US9598398B2Mar 21, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations72
US11236099B2Feb 1, 2022
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations71
US12024505B2Jul 2, 2024
Heterocyclic compounds useful as modulators of acetylcholine receptors
TAKEDA PHARMACEUTICALS CO0 citations62
US11970483B2Apr 30, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations62
US10144743B2Dec 4, 2018
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO1 citations62
US12378256B2Aug 5, 2025
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations61
US12162864B2Dec 10, 2024
Condensed-cyclic compound
TAKEDA PHARMACEUTICALS CO0 citations60
US10717748B2Jul 21, 2020
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICALS CO0 citations52
US9624184B2Apr 18, 2017
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations51
TAKEDA PHARMACEUTICAL
6 patentsUS9193709B2Nov 24, 2015
1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
TAKEDA PHARMACEUTICAL8 citations92
US8871766B2Oct 28, 2014
Heterocyclic compounds
TAKEDA PHARMACEUTICAL8 citations92
US8865717B2Oct 21, 2014
Heterocyclic compounds
TAKEDA PHARMACEUTICAL8 citations92
US8648079B2Feb 11, 2014
Heterocyclic compounds
TAKEDA PHARMACEUTICAL13 citations92
US9296746B2Mar 29, 2016
Heterocyclic compound
TAKEDA PHARMACEUTICAL3 citations72
US8940758B2Jan 27, 2015
Fused heterocyclic compounds
TAKEDA PHARMACEUTICAL2 citations62